Plasma levels of granulocyte elastase during hemodialysis: Effects of different dialyzer membranes  by Hörl, Walter H. et al.
Kidney International, Vol. 28 (1985), pp. 791—796
Plasma levels of granulocyte elastase during hemodialysis:
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Plasma levels of granulocyte elastase during hemodlalysis: Effects of
different dialyzer membranes. Plasma levels of granulocyte elastase in
complex with a1-proteinase inhibitor during hemodialysis were inves-
tigated in 15 patients (37.4 3.2 years) undergoing maintenance
hemodialysis (47.0 12.9 months) with dialyzers made from cellulose
hydrate, cuprophan, polymethylmethacrylate, ethylene-vinyl alcohol
copolymer, and polyacrylonitrile. Cellulose hydrate membrane caused
a maximal increase of the plasma levels of granulocyte elastase in
complex with a1-proteinase inhibitor (E-aiPI: 1,659.0 256.8 ng/ml).
Patients dialyzed with polyacrylonitrile dialyzers failed to exhibit
comparable plasma levels of granulocyte elastase (E-a1Pl: 237.8 22.9
ng/ml). During hemodialysis plasma E-a1Pl values rose to a peak 643.0
174.7 ng/ml in patients on polymethylmethacrylate dialyzers, to 557.5
120.0 ng/ml on cuprophan dialyzers, but to only 381.9 54.0 iig/ml on
ethylene-vinyl alcohol copolymer dialyzers. Plasma lysozyme levels
decreased significantly in the presence of polyacrylonitrile and
polymethylmethacrylate membranes. We conclude that the degree of
PMNs stimulation depends on the nature of the dialyzer membrane
material. The following membranes induce a reaction of increasing
intensity: polyacrylonitrile, ethylene-vinyl alcohol copolymer,
cuprophan, polymethylmethacrylate, and cellulose hydrate.
Taux plasmatique de l'élastase granulocytaire pendant l'hémodialyse:
effets de différentes membranes dialytiques. Le taux plasmatique de
l'6lastase granulocytaire lie avec l'inhibiteur de al-protCinase (E-I alP)
a CtC CtudiC pendant l'hémodialyse chez 15 patients (ages de 37,4 3,2
ans) hCmodialys6s chroniques (depuis 47,0 12,9 mois) avec des
dialyseurs a fibres creuses faites d'hydrates de cellulose, de
cuprophane, de polym6thylmCthacrylate, de copolymCreCthylCne-vi-
nyl-alcool et de polyacrylonitrile. La membrane d'hydrate de cellulose
a provoquC une augmentation maximale des taux plasmatiques de
l'E-IalP (1659,0 256,8 ng/ml). Les sujets dialyses avec des dialyseurs
en polyacrylonitrile n'ont pas montrC des taux plasmatiques
comparables (E-IalP = 237,8 22,9 ng/ml). Pendant l'hCmodialyse,
l'E-IalP plasmatique a atteint un pic de 643,0 174,7 ng/ml chez les
patients dialyses sur polym6thylmCthacrylate, de 557,5 120,0 nglml
sur cuprophane, mais seulement de 381,9 54,0 ng/ml sur
copolymereCthylCne-vinyl-alcool. Les taux plasmatiques du lysozyme
ont significativement diminuC en presence des membranes de
polyacrylonitrile et de polymethylm&hacrylate. Nous concluons que Ic
degrC de stimulation granulocytaire depend de la nature de Ia membrane
du dialyseur. Les membranes suivantes produisent une rCaction
d'intensitC croissante : polyacrylonitrile, copolymereethylgene-vinyl-
alcool, cuprophane, polymCthylm6thacrylate, et hydrate de cellulose.
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Transient granulocytopenia occurs in patients during the
initial phases of hemodialysis with ceilulosic membranes [1—4].
Such leukopenia results from pulmonary sequestration of leu-
kocytes provoked by complement-derived fragments [5—8].
Neutrophil granulocytes contain the neutral proteinases
elastase, cathepsin G, and collagenase. The activity of
proteases from human polymorphonuclear neutrophils on blood
smears was tested during hemodialysis with cuprophan hollow-
fiber dialyzers [9—12]. Granulocyte elastase is probably largely
responsible for tissue death, both because of its broad substrate
specifity and its abundance in the PMN leukocytes. In vitro, it
degrades various plasma proteins such as transferrin, im-
munglobulins, fibronectin, and several clotting factors (F I, III,
V, VII, VIII, XII, XIII) (for review, see [13].) Granulocyte
elastase and cathepsin 0 also cause a limited degradation of the
third and fifth complement factor of human complement [14,
15]. On the other hand, both C3a and C5a activate granulocytes.
Complement activation was temporally correlated with
hemodialysis leukopenia using cuprophan hollow-fiber dialyz-
ers. By contrast, patients dialyzed with polyacrylonitrile dialyz-
ers failed to exhibit hemodialysis leukopenia and displayed only
very modest increases in their plasma C3a levels [16]. Further-
more, during hemodialysis, plasma C3a rose from 401 to 6,325
ng/ml on cuprophan dialyzers, but from 426 to only 3,637 in
patients on cellulose acetate devices [17].
We have, therefore, attempted to characterize the changes in
plasma levels of granulocyte elastase in patients undergoing
maintenance hemodialysis, with particular reference to the
effects of cellulosic membranes and with noncellulosic mem-
brane formations, which have been reported to be more com-
patible with blood [3, 4, 16—18].
Methods
Patients
Fifteen chronically uremic patients (7 male and 8 female),
aged 57.4 3.2 years (mean SEM, range 26 to 79) undergoing
regular hemodialysis treatment (RDT) for 47.0 12.9 months
(range 6 to 132) were studied. Hemodialysis was performed 11.3
0.3 hr weekly using five different dialyzers in ten patients and
three different dialyzers in five patients. Each patient served as
his or her own control. The primary kidney disease was chronic
glomerulonephritis in seven cases, polycystic kidney disease in
two cases, diabetic glomerulosclerosis in three cases, intersti-
tial nephntis in two cases, and tumor nephrectomy in one case.
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Predialysis plasma concentration of creatinine was 11.6 0.98
mg/dl and of urea, 158.4 12.4 nigldl. Patients were each
dialyzed with dialyzers made from cellulose hydrate (Secon
133, Secon, GOttingen, Federal Republic of Germany),
cuprophan (Hemofiow D2, Fresenius, Oberursel, Federal Re-
public of Germany), polymethylmethacrylate (Filtryzer, Toray,
Tokyo, Japan), ethylene-vinyl alcohol copolymer (KF 101,
Salvia, Homburg, Federal Republic of Germany) and
polyacrylonitrile (Biospal 2400 S, Hospal, Lyon, France).
Sampling procedures
Whole blood samples were drawn from the patients' arterio-
venous fistula prior to dialysis and immediately after comple-
tion of dialysis. During the hemodialysis procedure, blood
samples were obtained at 30 and 120 mm. All blood samples
were anticoagulated immediately with sodium citrate.
Assay procedures
Plasma was separated from the sample within 30 mm after its
collection to prevent leakage of leukocyte constituents. The
plasma specimens were stored at —30°C until assayed. The
measurement of plasma levels of the granulocyte elastase in
complex with a1-proteinase inhibitor (E-a1PI) was performed
with a highly sensitive enzyme-linked immunoassay [19]. The
inhibitory activities of a1-proteinase inhibitor (ajPI) and of
a2-macroglobulin (a2M) were measured with a commercial test
systems (Boehringer, Mannheim, Federal Republic of Ger-
many). Plasma concentrations of a1PI and cs2M were evaluated
by nephelometer. Plasma total protein and non-TCA precipit-
able plasma protein fraction were measured according to the
method of Lowry et al [20]. Lysozyme was determined
turbidimetrically (Behring, Marburg, Federal Republic of Ger-
many).
Statistics
All values are given as mean SEM. For multiple compari-
sons of data obtained at different time points, an analysis of
variance (ANOVA) was used.
Results
The effect of hemodialysis therapy on plasma E-a1PI levels is
shown in Figure 1. Cellulose hydrate membrane caused a
maximum E-a1PI concentration of 1,659.0 256.8 ng/ml (P <
0.001). The increase of plasma E-ajPI value was also significant
after 120 mm of hemodialysis (P < 0.01) in comparison to all
other membranes. Cuprophan membrane induced an E-ajPI
increase of 557.5 120.0 ng/ml, whereas maximal E-a1PI
values of 643.0 174.7 nglml were measured in the presence of
the polymethylmethacrylate membrane. Both membranes
caused significantly higher E-a1PI levels at the end of
hemodialysis compared with the polyacrylonitrile membrane
(237.8 22.9 nglml). Plasma E-a1PI values were 381.9 54.0
nglml at the end of dialysis using the ethylene-vinyl alcohol
copolymer membrane, and this increase was only statistically
different from the values obtained in the presence of cellulose
hydrate membrane.
Plasma a1PI concentrations and activities are shown in
Tables 1 and 2. Both parameters increased slightly during
hemodialysis. However, using an analysis of variance
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Fig. 1. Effect of different membrane materials on plasma levels of
granulocyte elastase in complex with a1-proteinase inhibitor (E-ajPI)
30 and 120 mm after the start and at the end (E) of hemodialysis.
Symbols are: , cellulose hydrate; Ill, cuprophan; ,
polymethylmethacrylate; , ethylene-vinyl alcohol copolymer; U,
Polyacrylonitrile. ap < 0.05 in comparison to the polyacrylonitrile
membrane at the end (E) of hemodialysis. bp < 0.01 in comparison to
all other membranes after 120 mm of hemodialysis. CJ. < 0,001 in
comparison to all other membranes at the end (E) of hemodialysis.
(ANOVA) for multiple comparisons of data, the effect of
different membrane materials was not significant statistically.
No significant change was found either when comparing
plasma a2M concentrations and activities during hemodialysis
using five different dialyzer membranes (Tables 3 and 4).
The effect of different membrane materials on plasma
lysozyme concentration is shown in Table 5. In comparison to
the cellulose hydrate and cuprophan membranes, there was a
significant decrease of plasma lysozyme concentration after 120
mm and at the end of hemodialysis using the polymethylmeth-
acrylate membrane. Polyacrylonitrile membrane caused signif-
icantly lower plasma lysozyme levels after 30 and 120 mm
compared with all other membranes and also at the end of
hemodialysis, polymethylmethacrylate membrane excepted.
However, plasma concentration of non-TCA precipitable
protein decreased during hemodialysis (Fig. 2). The plasma
concentrations fell from 886.1 72.9 to 558.5 62.9 /,Lg/ml (P
< 0.001) in the presence of the cellulose hydrate membrane,
from 921.8 59.7 to 556.1 48.7 sg/ml (P < 0.001) in the
presence of the cuprophan membrane, and from 1,019.4 111.3
to 625.2 70.1 g/m1 (P < 0.001) in the presence of the
polymethylmethacrylate membrane. The ethylene-vinyl alcohol
copolymer dialyzer caused a decrease of non-TCA precipitable
protein fraction from 871.9 87.4 to 609.8 68.9 g/m1 (P <
0.001) and the polyacrylonitrile dialyzer from 878.1 61.5 to
534.7 75.5 pg/ml (P < 0.001; Wilcoxon's paired test).
However, using an analysis of variance (ANOVA) for multiple
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Table 1. Effect of different membrane materials on plasma concentrations of the a1-proteinase inhibitor, mg/dl
Dialyzer Before dialysis 30 mm 120 mm End of dialysis
Cellulose hydrate 212.5 14.2 221.7 14.1 232.2 17.7(N = 10)
Cuprophan 220.8 18.2 233.2 18.5 239.6 16.4(N= 15)
Polymethylmethacrylate 236.6 16.0 255.2 18.5 268.6 21.4(N = 10)
Ethylene-vinyl alcohol copolymer 222.2 14.2 230.6 14.5 236.2 15.7
(N= 15)
Polyacrylonitrile 214.1 16.3 222.2 18.3 238.2 22.0(N = 15)
226.5 16.8
236.0 18.3
268.0 16.8
232.9 16.6
244.4 31.7
Mean values SEM.
Table 2. Effect of different membrane materials on plasma activities of the a1-proteinase inhibitor, U/mI
Dialyzer Before dialysis 30mm 120 mm End of dialysis
Cellulose hydrate 1.57 0.20 1.64 0.18 1.65 0.15
(N= 10)
Cuprophan 1.69 0.11 1.91 0.15 1.94 0.15
(N 15)
Polymethylmethacrylate 1.79 0.10 1.95 0.13 2.00 0.12(N = 10)
Ethylene-vinyl alcohol copolymer 1.83 0.12 1.86 0.11 1.84 0.12(N = 15)
Polyacrylonitrile 1.61 0.11 1.81 0.17 1.86 0.20(N= 15)
1.63 0.15
1.90 0.14
2.11 0.13
1.90 0.15
1.87 0.23
Mean values 5EM.
Table 3. Effect of different membrane materials on plasma concentrations of a2-macroglobulin, mgldl
Dialyzer Before dialysis 30mm 120 mm End of dialysis
Cellulose hydrate 144.4 12.9 142.4 12.1 144.5 11.1(N = 10)
Cuprophan 147.6 12.7 147.8 10.3 155.6 10.3
(N= 15)
Polymethylmethacrylate 142.7 11.0 147.8 13.1 153.2 16.1(N = 10)
Ethylene-vinyl alcohol copolymer 160.7 15.3 160.4 16.6 163.0 16.9(N = 15)
Polyacrylonitrile 138.2 11.3 144.2 11.2 144.8 10.8
(N= 15)
141.7 11.5
144.4 13.1
153.9 13.3
166.7 17.1
153.2 13.8
Mean values SEM.
comparisons of data, the effect of different membrane materials
was not significant statistically.
Discussion
In the present study, the effect of different membrane mate-
rials (cellulose hydrate, cuprophan, polymethylmethacrylate,
ethylene-vinyl alcohol copolymer, and polyacrylonitrile) on the
plasma levels of granulocyte elastase during hemodialysis was
investigated. Cellulose hydrate membrane caused a maximum
level of E-ajPI of 1,659.0 256.8 nglml. The lowest plasma
E-a1PI values were observed using the polyacrylonitrile mem-
brane. Patients dialyzed with polysulfone dialyzers also dis-
played only very modest increases in their plasma E-a1PI levels
during hemodialysis [21]. Similar results were obtained in
patients dialyzed with ethylene-vinyl alcohol copolymer dialyz-
ers. Cuprophan and polymethylmethacrylate membranes
caused a significantly higher increase of plasma E-a1PI values
(Fig. 1).
The intensity of complement activation during hemodialysis
is determined by the type of dialysis membrane and whether it
is new or reused [16, 22—25). Noncellulosic membrane formu-
lations have been reported to be more compatible with blood
than the cellulosic membrane [3, 4, 16, 18, 21]. Significant
complement activation and anaphylatoxin formation were ob-
served in patients dialyzed with cuprophan hollow-fiber mem-
branes [6—8, 16, 17, 26]. By contrast, hemodialyzers containing
polyacrylonitrile membrane promoted very little complement
activation [161, a fact that correlates well with our observation
that this membrane activates very little PMNs (Fig. 1). How-
ever, polymethylmethacrylate surfaces caused only a small
degree of complement activation [241, whereas relative high
plasma E-a1PI levels were observed in the present study. The
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Table 4. Effect of different membrane materials on plasma activities of a2-macroglobulin, U/mi
Dialyzer Before dialysis 30mm 120 mm End of dialysis
Cellulose hydrate 5.26 0.63 5.77 0.66 5.43 0.53
(N= 10)
Cuprophan 5.30 0.35 5.71 0.40 5.60 0.38
(N= 15)
Polymethylmethacrylate 5.74 0.62 5.89 0.63 6.06 0.74(N = 10)
Ethylene-vinyl alcohol copolymer 5.14 0.45 5.11 0.49 5.35 0.46(N = 15)
Polyacrylonitrile 4.99 0.42 5.15 0.50 5.40 0.41
(N= 15)
5.60 0.58
5.53 0.44
6.15 0.72
5.39 0.43
5.55 0.46
Mean values SEM.
Table 5. Effect of different membrane materials on plasma lysozyme concentration, gluier
Dialyzer Before dialysis 30mm 120 mm End of dialysis
Cellulose hydrate 3.53 0.34 3.69 0.32 3.87 0.36
(N= 10)
Cuprophan 3.87 0.31 3.77 0.35 3.81 0.36
(N= 15)
Polymethylmethacrylate 3.91 0.31 2.91 0.29 2.35* 0.19(N = 10)
Ethylene-vinyl alcohol copolymer 3.27 0.15 3.32 0.20 3.33 0.23
(N= 15)
Polyacrylonitrile 3.37 0.28 1.79** 0.17 1.14** 0.16(N = 15)
3.84 0.36
3.80 0.31
2.44* 0.23
3.40 0.24
1.66*** 0.29
Mean values SEM.
* P < 0.01 in comparison to the cellulose hydrate and cuprophan membranes.
** P < 0.01 in comparison to all other membranes." P < 0.01 in comparison to all other membranes except the polymethylmethacrylate.
1,200
I
polyacrylonitrile) should also be taken into account. Mean
I plasma E-a1PI concentrations before hemodialysis were in a
I ñ range between 127.1 13.6 (ethylene-vinyl alcohol copolymer)
and 207.3 58.4 ng/ml (cellulose hydrate). The highest E-a1PI
900 levels were found during hemodialysis with cellulose hydrate
I dialyzers. Therefore, the E-a1PI values measured on the insti-I tution of hemodialysis are not the result of the last hemodialysis
NIr'l and not related to the sequence of the use of the different
-
600 flfl] i L I I i1il, I dialyzers. Recent studies from our laboratory showed E-aiPI
concentrations of 112.3 10.3, 151.1 13.2, 174.4 25.0 ng/ml
[11] and 188 20 ng/ml [9] before dialysis.
It is evident that daily differences exist in uremic patients
Plasma E-aiPI levels, however, are always significantly higher300 than mean E-a1PI values of healthy controls (70.3 4.4 nglml).
It can be argued that results of E-aiPI, ctjPI, a2M, and
lysozyme could be given not only per ml of plasma but also on
a plasma protein basis because large variations in protein
0 concentrations might have been observed in some patients.
0 30 120 E However, the significance of the changes in plasma E-a1PI and
Dialysis time, mm lysozyme values described was not influenced when calculated
Fig. 2. Effect of different membrane materials on plasma concentration on a plasma protein basis.
of non-TCA precipitable protein 30 and 120 mm after the start and at The control of proteolytic activities in blood and other tissues
the end (E) of hemodialysis. Symbols are as Fig. 1. . .is exerted, pnmanly, by nine plasma proteins [27]. Alpha1-
proteinase inhibitor (alphai-antitrypsin) and alpha2-
macroglobulin are the major plasma antiproteinases that mac-
role of different sterilization procedures (gamma radiation: tivate granulocyte elastase [27, 28]. Therefore, both the plasma
polymethylmethacrylate; ethylene oxide: cellulose hydrate, concentrations and the activities of these proteinase inhibitors
cuprophan, ethylene-vinyl alcohol copolymer, and were determined. There was a significant increase of a1PI and
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a2M activities (U/mi) and concentrations (mg/dl), but, on a
plasma protein basis, these effects were abolished. A previous
study [9] also failed to exhibit changes of a1PI activity and
concentration during the first 3 of 5 hr of hemodialysis, when
the weight was kept constant. In a further study with 70
patients, a significant increase of plasma a1PI concentration
(mg/dl) was observed during hemodialysis but a1PI activity
remained constant [11].
By contrast, hemodialysis with cuprophan membranes was
found to produce a significant decrease of alpha1-antitrypsin.
This decrease was particularly obvious during the first 30 mm,
but it lasted for 240 mm in most patients [29]. It is quite possible
that the liberation from granulocyte elastase together with other
lysosomal enzymes might lead to repeated local proteinase-
antiproteinase imbalances. It was suggested that proteases
released from granulocytes are rapidly bound to alpha1-
antitrypsin, causing a decrease of this antiprotease [29]. Our
results do not, however, support this theory.
Specific granules of PMNs contain lysozyme [30, 31], colla-
genase [32], B-12 binding protein, and lactoferrin. Azurophil
granules also contain lysozyme [30, 31]. Leukocyte activation
of cell death is associated with the release of lysozyme [33] and
lactoferrin [18, 34]. It was shown recently that leukocytes
leaving the cellophan dialyzer had a significantly decreased
lysozyme content [33]. In the present study, the plasma
lysozyme levels before, during, and after hemodialysis were
measured. Before hemodialysis, plasma lysozyme values were
significantly elevated (Fig. 1.) compared with healthy controls
(0.3 to 0.9 g/liter). Patients dialyzed with cellulose hydrate,
cuprophan, or ethylene-vinyl alcohol copolymer dialyzers
failed to exhibit significant changes of plasma lysozyme values.
By contrast, there was a significant decrease of plasma
lysozyme concentration during and immediately after
hemodialysis in the presence of polyacrylonitrile membrane.
Lysozyme is a basic polypeptide composed of 120 amino acids
and with a molecular weight of 15,000. The mechamism of
lowered plasma lysozyme concentration during hemodialysis
with polyacrylonitrile or polymethylmethacrylate membranes is
unclear. We cannot exclude that this basic polypeptide binds on
these two dialyzers. It is unlikely that lysozyme is eliminated
during hemodialysis, since plasma levels remain constant using
the ethylene-vinyl alcohol copolymer hollow fiber, which is
superior in the permeability of middle molecular weight sub-
stances and proteins compared with the other cellulosic and
noncellulosic membranes.
Trichloroacetic acid (TCA) is widely used as a protein
coagulant in the preparation of protein-free sera. The elimina-
tion of bound water and its replacement by the strongly
non-polar Cl3 C.C-radical destroys the solubiity of proteins
[35]. The mean values of this small molecular protein fraction
obtained from patients with posttraumatic acute renal failure
were 1.65 0.11 mg/mi [36], compared with 1.036 0.029
mg/mi from patients on regular hemodialysis treatment [11] and
0.246 0.019 mg/mi from health controls [36]. Non-TCA-
precipitable plasma protein fraction decreased during
hemodialysis, independent of the dialyzer used (Fig. 2.).
In summary, the observations reported here are quite com-
patible with what is currently known about the biocompatibility
of dialysis membranes. Polyacrylonitrile dialyzers provoke
minimal C3a [16, 22] and E-a1PI (Fig. 1 .)formation and consis-
tently fail to induce extensive leukopenia [4, 21, 22]. The results
of the comparison of the effects of five different dialyzers on the
plasma content in elastase complexed with cr1-proteinase inhib-
itor (E-aiPI) indicate that this parameter may be a further index
of biocompatibiity.
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